A tetravalent dengue nanoparticle stimulates antibody production in mice

被引：0
|
作者：
Elisângela F Silva
Mariana Orsi
Ângela L Andrade
Rosana Z Domingues
Breno M Silva
Helena RC de Araújo
Paulo FP Pimenta
Michael S Diamond
Eliseu SO Rocha
Erna G Kroon
Luiz CC Malaquias
Luiz FL Coelho
机构：
[1] Federal University of Alfenas,Institute of Biomedical Science
[2] Federal University of Ouro Preto,Department of Chemistry
[3] Federal University of Minas Gerais,Department of Chemistry
[4] Federal University of Ouro Preto,Department of Biological Sciences
[5] Laboratory of Medical Entomology,Departments of Medicine, Molecular Microbiology, Pathology & Immunology
[6] Instituto René Rachou,Virus Laboratory, Department of Microbiology, Institute of Biological Sciences
[7] Fundação Oswaldo Cruz,Institute of Biomedical Science
[8] Washington University School of Medicine,undefined
[9] Federal University of Minas Gerais,undefined
[10] Federal University of Alfenas,undefined
来源：
Journal of Nanobiotechnology | / 10卷
关键词：
inactivated Dengue vírus; Nanoparticles; humoral response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Development of a tetravalent dengue DNA vaccine
    Liew, SC
    Reid, MP
    Aaskov, JG
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 28 : S31 - S32
  • [32] Live attenuated tetravalent dengue vaccine
    Bhamarapravati, N
    Sutee, Y
    [J]. VACCINE, 2000, 18 : 44 - 47
  • [33] It stimulates antibody production, but what does that mean?
    Watanabe, ME
    [J]. SCIENTIST, 1999, 13 (03): : 9 - 9
  • [34] Tetravalent formulation of polymeric nanoparticle-based vaccine induces a potent immune response against dengue virus
    Khan, Rafiq Ahmad
    Ahmed, Farhan
    Afroz, Sumbul
    Khan, Nooruddin
    [J]. BIOMATERIALS SCIENCE, 2022, 10 (11) : 2917 - 2928
  • [35] IMMUNOGENICITY OF A NOVEL TETRAVALENT DENGUE ENVELOPE PROTEIN DOMAIN III-BASED ANTIGEN IN MICE
    Fahimi, Hossein
    Sadeghizadeh, Majid
    Hassan, Zuhair M.
    Auerswald, Heidi
    Schreiber, Michael
    [J]. EXCLI JOURNAL, 2018, 17 : 1054 - 1068
  • [36] CHARACTERIZATION OF THE NEUTRALIZING ANTIBODY RESPONSE IN BASELINE SERONEGATIVE CHILDREN, ADOLESCENT AND ADULT RECIPIENTS OF A TETRAVALENT DENGUE VACCINE
    Zahralban-Steele, Melissa
    Kaiser, Maima
    Rindfleisch, Tim
    Bohning, Kelly
    Norwood, Brooke
    Dominguez, David
    DeMaso, Christina
    Sharma, Mayuri
    Dean, Hansi
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 51 - 51
  • [37] Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine
    Maier, Sandra B.
    Huang, Xiao
    Massad, Eduardo
    Amaku, Marcos
    Burattini, Marcelo N.
    Greenhalgh, David
    [J]. MATHEMATICAL BIOSCIENCES, 2017, 294 : 15 - 32
  • [38] A safe and recombinant, tetravalent dengue vaccine induces very high antibody titers that neutralise all serotypes
    Huber, A.
    [J]. SWISS MEDICAL WEEKLY, 2009, 139 (9-10) : 15S - 15S
  • [39] Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus
    Lazo, Laura
    Izquierdo, Alienys
    Suzarte, Edith
    Gil, Lazaro
    Valdes, Iris
    Marcos, Ernesto
    Alvarez, Mayling
    Romero, Yaremis
    Guadalupe Guzman, Maria
    Guillen, Gerardo
    Hermida Cruz, Lisset
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2014, 58 (04) : 219 - 226
  • [40] Tetravalent vaccine for dengue fever shows promise
    不详
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (03) : 237 - 237
12345